Trump Media and Technology Group Corp vs Roivant Sciences Ltd. Common Shares — how do they compare? Trump Media and Technology Group Corp trades at $8.12 (market cap $2.28B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 10.8× Trump Media and Technology Group Corp's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Trump Media and Technology Group Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Trump Media and Technology Group Corp for 17 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| DJT | ROIV | |
|---|---|---|
Market Cap | $2.28B | $24.72B |
Volume | 3,148,379 | 6,279,442 |
Sector | Media | Health |
52-Week High | $17.07 | $41.81 |
52-Week Low | $7.06 | $16.04 |
Typical Hold Time | 17 Days | 1 Days |
Enterprise Value | $2.35B | $20.99B |
Signals from Pluang's Aura AI — not financial advice
DJT trades at $8.11, down 1.34% with bearish technical signals. The company reported $3.68M revenue in 2025 but a net loss of $712M, with negative margins and cash flow challenges. Recent news highlights a proposed merger with TAE Technologies and ongoing volatility linked to political developments and strategic shifts.
Outlook remains high-risk due to persistent losses and speculative sentiment. The merger with TAE offers potential diversification into fusion energy, but profitability concerns and insider selling weigh on investor confidence. Key risks include execution hurdles and dependence on political narratives.
No Aura AI signal available yet.
Trailing returns across standard periods
Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →